M. Hoffknecht

736 total citations
17 papers, 495 citations indexed

About

M. Hoffknecht is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, M. Hoffknecht has authored 17 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in M. Hoffknecht's work include Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Mesenchymal stem cell research (2 papers). M. Hoffknecht is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Mesenchymal stem cell research (2 papers). M. Hoffknecht collaborates with scholars based in Germany and United States. M. Hoffknecht's co-authors include William Krüger, M Stockschläder, Peter Dreger, AR Zander, W. Zeller, Andrea Bacigalupo, Berthold Schalke, Uwe Hahn, H. Kabisch and N Schmitz and has published in prestigious journals such as Blood, Stem Cells and European Journal of Cancer.

In The Last Decade

M. Hoffknecht

17 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hoffknecht Germany 12 270 185 174 117 98 17 495
Mitsutoshi Kurosawa Japan 13 241 0.9× 140 0.8× 209 1.2× 176 1.5× 108 1.1× 49 610
DE Stepan United States 7 314 1.2× 149 0.8× 145 0.8× 93 0.8× 113 1.2× 9 503
R Spanedda Italy 13 290 1.1× 75 0.4× 173 1.0× 97 0.8× 64 0.7× 34 471
Hikaru Kobayashi Japan 12 300 1.1× 103 0.6× 132 0.8× 124 1.1× 162 1.7× 24 560
R. Fanin Italy 8 384 1.4× 93 0.5× 184 1.1× 139 1.2× 54 0.6× 12 519
R. Vimercati Italy 11 273 1.0× 119 0.6× 145 0.8× 192 1.6× 66 0.7× 26 437
Takayoshi Tachibana Japan 13 330 1.2× 88 0.5× 112 0.6× 137 1.2× 90 0.9× 81 530
Keiki Kawakami Japan 11 297 1.1× 105 0.6× 96 0.6× 107 0.9× 125 1.3× 47 488
Xavier Cahu France 12 221 0.8× 109 0.6× 146 0.8× 114 1.0× 80 0.8× 22 414
Michihiko Masuda Japan 12 175 0.6× 86 0.5× 117 0.7× 111 0.9× 98 1.0× 27 375

Countries citing papers authored by M. Hoffknecht

Since Specialization
Citations

This map shows the geographic impact of M. Hoffknecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hoffknecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hoffknecht more than expected).

Fields of papers citing papers by M. Hoffknecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hoffknecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hoffknecht. The network helps show where M. Hoffknecht may publish in the future.

Co-authorship network of co-authors of M. Hoffknecht

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hoffknecht. A scholar is included among the top collaborators of M. Hoffknecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hoffknecht. M. Hoffknecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hänel, Mathias, Nicolaus Kröger, Martin Bornhäuser, et al.. (2002). Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Annals of Hematology. 81(2). 96–102. 35 indexed citations
2.
Kröger, Nicolaus, M. Hoffknecht, William Krüger, et al.. (2000). Allogeneic bone marrow transplantation for refractory mantle cell lymphoma. Annals of Hematology. 79(10). 578–580. 21 indexed citations
3.
Hänel, Mathias, Nicolaus Kröger, M. Hoffknecht, et al.. (2000). ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas. Annals of Hematology. 79(6). 304–311. 9 indexed citations
4.
Kröger, Nicolaus, M. Hoffknecht, Peter Dreger, et al.. (1998). Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy. Bone Marrow Transplantation. 21(1). 55–57. 36 indexed citations
5.
Kröger, Nicolaus, M. Hoffknecht, Mathias Hänel, et al.. (1998). Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplantation. 21(12). 1171–1175. 28 indexed citations
6.
Weh, H.J., R. Zschaber, D. Braumann, et al.. (1998). A Randomized Phase III Study Comparing Weekly Folinic Acid(FA) and High-Dose 5-Fluorouracil (5-FU) with Monthly 5-FU/FA (days 1-5) in Untreated Patients with Metastatic Colorectal Carcinoma. Oncology Research and Treatment. 21(5). 403–407. 24 indexed citations
7.
Hegewisch-Becker, S., William Krüger, M. Hoffknecht, et al.. (1997). Bone Marrow Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. Hämatologie und Bluttransfusion. 16(5). 704–710. 62 indexed citations
8.
Hartung, G., W. Queißer, E. Hagmüller, et al.. (1996). Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity. Oncology Research and Treatment. 19(1). 62–67. 4 indexed citations
9.
Krüger, William, Ingo Sobottka, M Stockschläder, et al.. (1996). Fatal Outcome of Disseminated Candidosis after Allogeneic Bone Marrow Transplantation under Treatment with Liposomal and Conventional Amphotericin-B. A Report of 4 Cases with Determination of the Mic Values. Scandinavian Journal of Infectious Diseases. 28(3). 313–316. 3 indexed citations
10.
Hassan, H.T., W. Zeller, M Stockschläder, et al.. (1996). Comparison between Bone Marrow and G‐CSF‐Mobilized Peripheral Blood Allografts Undergoing Clinical Scale CD34 + Cell Selection. Stem Cells. 14(4). 419–429. 25 indexed citations
11.
Stockschläder, M, William Krüger, Martin A. Horstmann, et al.. (1996). Use of cryopreserved bone marrow in unrelated allogeneic transplantation.. PubMed. 17(2). 197–9. 16 indexed citations
12.
Marmont, A, Andrea Bacigalupo, Peter Dreger, et al.. (1996). Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood. 88(9). 3621–3625. 163 indexed citations
13.
Horstmann, Martin A., M Stockschläder, William Krüger, et al.. (1995). Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results. Annals of Hematology. 71(2). 77–81. 22 indexed citations
14.
Krüger, William, M Stockschläder, Carolina Berger, et al.. (1995). Experience with liposomal Amphotericin‐B in 60 patients undergoing high‐dose therapy and bone marrow or peripheral blood stem cell transplantation. British Journal of Haematology. 91(3). 684–690. 20 indexed citations
16.
Stockschläder, M, William Krüger, W. Zeller, et al.. (1995). Use of cryopreserved bone marrow in allogeneic bone marrow transplantation.. PubMed. 15(4). 569–72. 22 indexed citations
17.
Weh, H.J., M. Hoffknecht, Peter Holzer, et al.. (1995). 754 5-FU/FA IV bolus therapy vs weekly high-dose 5-FU/FA 24-hour infusion in metastatic colorectal carcinoma: Preliminary results of an ongoing randomized phase III study. European Journal of Cancer. 31. S158–S158. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026